Marchex, Inc. (MCHX) Bundle
You're looking at Marchex, Inc. (MCHX) and seeing a mixed signal, and honestly, you're right to be cautious. The Q3 2025 results show the real tension in their AI-driven transformation: GAAP revenue dropped to $11.5 million, which signals the continued pressure from their platform migration. But here's the quick math on the operational side: despite reporting a net loss of $1.0 million for the quarter, the company actually generated an Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization-a good proxy for operational cash flow) gain of $1.1 million when you strip out reorganization costs. This tells me the core business model is improving its operating leverage, even as the top line shrinks. The near-term risk is clear-revenue is still soft-but the opportunity is the proposed $16.4 million acquisition of Archenia, which should defintely accelerate their move into outcome-based solutions. That's the pivot we need to watch.
Revenue Analysis
You need to know where Marchex, Inc. (MCHX) is making its money right now, and the short answer is that their revenue is contracting slightly due to a major internal transition, but they are laying the groundwork for future growth with a clear focus on AI. The company's Trailing Twelve Months (TTM) revenue as of November 2025 stands at $47.53 million USD, representing a modest -1.23% decline year-over-year from 2024's $48.12 million USD in revenue. This isn't a growth story yet, but it's a story of strategic change.
The core of Marchex's revenue comes from its suite of AI and conversational intelligence solutions, which are essentially Software as a Service (SaaS) products. These solutions help clients-particularly in high-value verticals like automotive and healthcare-optimize customer journeys and accelerate revenue. The primary revenue driver is the Marchex Engage platform (formerly known as OneStack), which provides prescriptive analytics (actionable insights derived from data) to sales and marketing teams.
Here's the quick math on the 2025 quarterly trend, which shows the impact of this transition:
| Quarter | GAAP Revenue (2025) | Year-over-Year Change (vs. 2024) |
|---|---|---|
| Q1 2025 | $11.4 million | Down from $11.6 million |
| Q2 2025 | $11.7 million | Down from $12.1 million |
| Q3 2025 | $11.5 million | Down from $12.6 million |
The sequential revenue dip from Q2 to Q3 2025, and the overall year-over-year declines, are defintely a risk factor, but they are largely tied to one major internal change.
Platform Migration and Future Revenue Shifts
The most significant change in Marchex's revenue stream is the ongoing migration of over 1,000 customers from legacy platforms onto the new, unified Marchex Engage platform. This process has caused revenue dilution-some customers simply didn't migrate, and others are transitioning-which is the main offset to the favorable impact of new sales and existing customer upsells. The company anticipates this migration-related dilution will continue to impact Q4 2025 results due to seasonality and macroeconomic headwinds.
The future of the revenue profile is tied to strategic acquisitions. Marchex has an agreement to acquire Archenia, a performance-based customer acquisition company, for a $10 million convertible note and a potential earn-out. This acquisition is a critical move because it shifts the revenue model to include performance-based customer qualification, where clients pay for verified, AI-validated outcomes like appointments and sales.
This is a big step toward becoming a more comprehensive, outcome-focused solution provider. Post-acquisition, the management believes the combined company could achieve a revenue run rate of approximately $60 million annualized (or $15 million quarterly) and target a 15-20% revenue growth range in 2026.
- The core business is SaaS-based conversational intelligence.
- Current revenue softness is a direct result of platform migration.
- Acquisition of Archenia is the key near-term catalyst for growth.
For a deeper dive into who is betting on this turnaround, you should check out Exploring Marchex, Inc. (MCHX) Investor Profile: Who's Buying and Why?
Profitability Metrics
You need to know if Marchex, Inc. (MCHX) is finally turning the corner on profitability after its multi-year transition to a Software-as-a-Service (SaaS) model. The short answer is: the core business is showing signs of operating leverage, but GAAP (Generally Accepted Accounting Principles) net profitability remains elusive for the full year 2025.
Looking at the trailing twelve months (TTM) of data, Marchex, Inc.'s TTM revenue is approximately $47.53 million. This revenue base generated a TTM Gross Profit of about $16.85 million, which translates to a Gross Profit Margin of roughly 35.45%. That's a critical number, but it tells a mixed story when you look at the industry.
Gross Margin: The Efficiency Gap
A 35.45% Gross Profit Margin for Marchex, Inc. is a clear signal of their business model. For a pure-play SaaS company, the industry benchmark is typically in the 70% to 80%+ range, showing low marginal costs to serve an extra customer. Marchex, Inc.'s margin is much lower because their conversational intelligence platform, which uses AI, has a higher cost-to-serve-think cloud compute and data center expenses-which is common for AI-centric products that often see margins in the 50% to 60% range.
The good news is the trend is moving in the right direction. Management anticipates improved gross profit margins in 2025 compared to 2024, and the Q1 2025 gross margin already increased by approximately 8% compared to Q1 2023. That's a solid improvement, but they still have a significant way to go to reach true SaaS-level efficiency.
- Gross Margin (TTM 2025): 35.45%
- SaaS Industry Benchmark: 70% to 80%+
- Action: Watch for continued margin expansion as their platform migration nears completion.
Operating and Net Profitability: A Turnaround in Progress
The company's focus has been on achieving Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), a non-GAAP measure of operating profit, which strips out non-cash and one-time costs like reorganization expenses. This is where the inflection point is visible:
Marchex, Inc. aims for an Adjusted EBITDA annual run rate of more than $6.0 million in 2025, showing a clear path to core operating profitability as cost efficiencies from the platform migration take hold. In fact, they recorded an Adjusted EBITDA gain of $1.1 million (excluding reorganization costs) in Q3 2025, which was a 50% sequential improvement over Q2 2025.
However, the GAAP Net Profit Margin for the TTM period ending Q1 2025 remains a loss of -11.43%. While Q2 2025 did see a brief swing to GAAP Net Income of $0.1 million, the Q3 2025 net loss was $1.0 million. This volatility is typical during a major technology platform migration (a 'OneStack' initiative), but it means they are not yet consistently profitable on a GAAP basis.
Here's the quick math on the quarterly swing:
| Metric | Q2 2025 | Q3 2025 |
|---|---|---|
| GAAP Revenue | $11.7 million | $11.5 million |
| GAAP Net Profit (Loss) | $0.1 million (Income) | $1.0 million (Loss) |
| Adj. EBITDA (excl. Reorg.) | $0.7 million (Gain) | $1.1 million (Gain) |
The median operating margin for public SaaS companies in Q1 2025 was -9%, so Marchex, Inc.'s TTM Net Profit Margin of -11.43% is in the ballpark for a growing, smaller-cap SaaS company that is still investing heavily. The focus is on operating leverage-the ability to grow revenue faster than operating expenses-which is what the steady rise in Adjusted EBITDA suggests they are achieving. You can dive deeper into the strategic drivers behind these numbers in Breaking Down Marchex, Inc. (MCHX) Financial Health: Key Insights for Investors.
Debt vs. Equity Structure
You're looking at Marchex, Inc. (MCHX) because you want to know how they fund their growth, and honestly, their capital structure is lean-very lean. The direct takeaway is that Marchex relies overwhelmingly on equity, keeping its debt load minimal, which drastically reduces financial risk but can limit the speed of non-dilutive expansion.
As of the 2025 fiscal year, Marchex's total debt is only about $1.22 million. This is split between $721.00 thousand in long-term debt and $495.00 thousand in short-term debt. That's a tiny debt profile for a public company, which tells you they have a strong balance sheet with high financial flexibility.
Here's the quick math on their leverage, which is the Debt-to-Equity (D/E) ratio: Marchex's D/E ratio sits at approximately 0.04. This is a signficant outlier when you look at the industry. The average for Advertising Agencies is closer to 0.79, and even the broader Information Technology sector averages around 0.48. Marchex's ratio is defintely a conservative approach, favoring shareholder equity over creditor obligations.
This low leverage means the company is not paying much in interest expense, but it also means they have a lot of untapped borrowing capacity. While there are no public credit ratings from major agencies like S&P or Moody's-which is typical for a company with this little debt-the financial strength is clear. They have chosen to fund their operations and growth primarily through retained earnings and equity issuances.
Still, recent activity shows how they strategically use a blend of debt and equity for targeted growth. On November 13, 2025, Marchex entered into an Agreement in Principle to acquire Archenia, Inc., using a $10 million convertible promissory note at 6%. This is a smart, hybrid financing tool.
- Debt Component: The $10 million note provides immediate capital for the acquisition.
- Equity Component: The note is convertible into Class B common stock at $1.80 per share, meaning the debt can be wiped off the balance sheet and converted into equity, which avoids a cash repayment and dilutes shareholders instead.
This convertible note is a clear signal: Marchex is willing to use debt for strategic, accretive acquisitions, but they build in an equity escape hatch (conversion) to keep their long-term leverage low and maintain a capital-light structure. You can read more about the company's long-term strategy, which this acquisition supports, in their Mission Statement, Vision, & Core Values of Marchex, Inc. (MCHX).
For your own analysis, this is the key takeaway: Marchex's current financial health is not constrained by debt, but its future growth is dependent on either generating significant internal cash flow or executing on this convertible financing strategy without excessive shareholder dilution. The low-leverage model is safe, but it requires flawless execution on M&A and organic growth for maximum return on equity (ROE).
Liquidity and Solvency
When you look at Marchex, Inc. (MCHX)'s short-term financial health, the immediate takeaway is that their liquidity position is defintely solid, but you need to pay close attention to the cash burn from operations. The company has more than enough current assets to cover its immediate bills, but the cash flow statement shows they are still using cash to run the business.
For the period ending September 30, 2025, Marchex, Inc. (MCHX) shows a strong ability to meet its short-term obligations, which is what liquidity is all about. Here's the quick math on their key ratios, which measure how easily they can convert assets to cash to pay liabilities (short-term debts):
- Current Ratio: The ratio is 2.53 (Current Assets of $20.403 million / Current Liabilities of $8.065 million). This means for every dollar of short-term debt, the company has $2.53 in current assets to cover it. That's a very comfortable buffer.
- Quick Ratio: This is a tougher test, excluding assets like inventory (which Marchex, Inc. (MCHX), as a software company, doesn't really have). The Quick Ratio stands at approximately 2.20. (Cash and Accounts Receivable of $17.717 million / Current Liabilities of $8.065 million). This high number confirms their strong ability to pay liabilities using only their most liquid assets.
The strength here comes from having a lot of cash and accounts receivable, which is money owed by customers. That's a good sign of operational health, but it doesn't tell the whole story.
Working Capital and Cash Flow Trends
The company's working capital (Current Assets minus Current Liabilities) is also robust, sitting at $12.338 million as of Q3 2025. This positive working capital trend is a clear strength, giving management flexibility to invest or weather unexpected costs. Still, the cash flow statement reveals a persistent challenge: cash used in operating activities was $1.5 million for the first nine months of 2025.
This negative operating cash flow, or cash burn, is the reason the company's cash and cash equivalents dropped from $12.8 million at the end of 2024 to $10.3 million by September 30, 2025. The management noted that some of this cash decrease was due to the timing of customer payments, but a sustained negative operating cash flow is a risk that eats into that healthy cash balance over time. You need to see that turn positive as the new platform migration nears completion and sales bookings accelerate. Exploring Marchex, Inc. (MCHX) Investor Profile: Who's Buying and Why?
Investing and Financing Activities
The investing and financing sections of the cash flow statement highlight the company's strategic shift. A major recent event is the agreement in principle to acquire Archenia, Inc., which involves a $10 million convertible promissory note. This is a significant financing activity that adds a new layer of complexity to the balance sheet, though the debt is convertible and not a straight cash outlay right now. This is a strategic investment in growth, but it does commit future resources.
Here's a quick look at the cash flow components for the nine months ending September 30, 2025, which maps the near-term risks and opportunities:
| Cash Flow Component | Trend (9 Months Ended 9/30/2025) | Implication for Liquidity |
|---|---|---|
| Operating Activities | Negative (-$1.5 million) | Cash is being used to run the business; requires monitoring. |
| Investing Activities | Likely Negative | Investment in the new platform and the Archenia acquisition signal future growth focus. |
| Financing Activities | Mixed/Strategic | The $10 million convertible note for the acquisition is a key future obligation/dilution risk. |
The risk is the cash burn continues while the company integrates the acquisition and waits for the new AI-powered platform to drive revenue. Action item: Demand clarity on the timeline for achieving positive cash flow from operations in the next two quarters.
Valuation Analysis
You're looking at Marchex, Inc. (MCHX) and trying to figure out if the recent stock dip makes it a bargain or a warning sign. The direct takeaway is that Marchex is a classic growth-stock situation-it's currently unprofitable, so traditional valuation metrics are skewed, but relative valuation suggests it might be slightly undervalued at its current price.
When a company is in a transition period, like Marchex is with its new AI-driven platforms, you have to look beyond a simple Price-to-Earnings (P/E) ratio. For the 2025 fiscal year, the Trailing Twelve Months (TTM) P/E ratio is a negative -14.9, which simply confirms the company is not profitable on a net income basis. That's a red flag for value investors, but it's common for companies focused on high-growth technology rollouts.
The stock has definitely been on a rough ride. Over the last 12 months leading up to November 2025, the stock price has fallen by about 25.89%. It has traded in a wide range, from a 52-week low of $1.26 to a high of $2.40. As of mid-November 2025, the stock is trading around $1.54 per share. That drop is a clear signal of market uncertainty, especially after the Q3 2025 earnings miss, where the company reported a loss of ($0.02) earnings per share, missing the consensus estimate of $0.01.
Here's the quick math on key valuation multiples, using the most recent 2025 data:
- Price-to-Book (P/B): The P/B ratio stands at 2.17. This is about 10.85% higher than its 3-year average of 1.96, suggesting the market is paying a slight premium over the company's net asset value.
- EV/EBITDA: The Forward Enterprise Value-to-EBITDA (EV/EBITDA) is 21.40. This is a high multiple, but with Q3 2025 Adjusted EBITDA improving sequentially to a gain of $0.6 million (or $1.1 million excluding reorganization costs), investors are betting on future operating leverage to bring that multiple down.
One thing you should know right away is that Marchex, Inc. is not a dividend stock. They don't pay one, so the dividend yield and payout ratios are 0.00% (N/A). The company is prioritizing reinvestment into its business, particularly the new AI-driven platform initiatives like Marchex Engage. If you want a cash return, this isn't the stock for you.
Analyst consensus is cautious, to be fair. The overall sentiment is a 'Reduce' rating, with a mix of 'Hold' and 'Sell' recommendations. The average analyst price target for 2025 is around $0.9485, which suggests a significant downside from the current price. Still, some relative valuation models actually peg the fair price between $1.63 and $2.20, implying the stock is currently undervalued by about 3.1%.
What this estimate hides is the execution risk of their platform migration and the successful integration of the Archenia acquisition, which is expected to help the combined entity target a $15 million quarterly revenue run rate in 2026. You need to weigh the current negative profitability against the projected growth, especially considering the Mission Statement, Vision, & Core Values of Marchex, Inc. (MCHX).
| Valuation Metric (2025 Fiscal Year) | Value | Interpretation |
|---|---|---|
| Stock Price (Mid-Nov 2025) | $1.54 | Down 25.89% over 12 months. |
| P/E Ratio (TTM) | -14.9 | Company is currently unprofitable. |
| P/B Ratio | 2.17 | Slight premium to book value. |
| Forward EV/EBITDA | 21.40 | High multiple, pricing in future growth/profitability. |
| Analyst Consensus | Reduce | Cautious outlook, average target near $0.95. |
Your next step should be to look closely at the Q4 2025 guidance, which anticipates revenue and Adjusted EBITDA will be sequentially lower due to seasonality and the final stages of customer migration, and see if that risk is already baked into the current price.
Risk Factors
You're looking at Marchex, Inc. (MCHX) because of its AI-driven conversational intelligence, but the near-term financial picture shows real headwinds. The core takeaway is this: the company's strategic pivot to a SaaS model is creating short-term revenue dilution and integration risks that, coupled with a tough macro environment, make achieving the 2025 run-rate goals a defintely stretch.
The company is in a crucial transition, and that always brings risk. We saw this play out in Q3 2025 when Marchex reported GAAP revenue of $11.5 million, which was a miss against analyst expectations and a sequential decline from Q2 2025's $11.7 million. This revenue softness is directly tied to the risks below, and you need to monitor them closely.
Operational and Strategic Execution Risks
The biggest internal risk is the ongoing technology platform migration, often called the OneStack initiative. While this move is smart for the long-term-it's about becoming a true Software-as-a-Service (SaaS) provider-it's causing immediate pain. Management itself acknowledged 'revenue migration dilution' as customers transition or, critically, decide not to migrate to the new Marchex Engage platform, which is anticipated to sequentially lower Q4 2025 revenue and Adjusted EBITDA. This is a classic platform-shift problem.
- Migration dilution is hitting revenue now.
- The proposed acquisition of Arcaneum/Arcadia, while strategically sound, introduces integration risk.
- Future growth depends entirely on the successful adoption of new AI-driven solutions.
Here's the quick math: Marchex's stated ambition for 2025 was an annualized revenue run rate of $50 million and an Adjusted EBITDA run rate of $6 million. Given the Q3 2025 Adjusted EBITDA was only $0.6 million (or $1.1 million excluding reorganization costs of $0.5 million), there is a significant gap to close in Q4. They need to accelerate sales bookings, and fast.
External and Market Risks
Marchex operates in a fiercely competitive market, and the macroeconomic climate isn't helping. The competition in conversational intelligence is intense and broad, coming from both specialized firms and larger platforms. Also, the company's focus on key verticals like automotive and auto services makes it vulnerable to sector-specific shocks.
Management has flagged increased uncertainty due to macroeconomic conditions, which directly impacts customer spending on marketing and technology. Plus, new federal tariffs are a specific external risk for their automotive vertical clients. You should also be aware of the stock's volatility; with a beta of 1.78, its price movements are significantly more pronounced than the broader market.
The market is competitive; you must watch customer churn.
Regulatory and Compliance Risks
For a company that deals primarily with customer conversations-calls and texts-regulatory compliance is a non-negotiable, material risk. The landscape for voice-related services is complex and constantly shifting. The primary concern is the Telephone Consumer Protection Act (TCPA), which strictly limits the use of autodialing systems, prerecorded voice messages, and SMS text communications.
A regulatory misstep could lead to significant fines or operational restrictions. Furthermore, there is an inherent risk that a regulatory body could impose new rules for IP communications technologies that are simply unsuitable or overly burdensome for Marchex's current operating model.
Marchex's mitigation strategy centers on its AI-driven platform, which aims to provide value and efficiency to customers, thereby driving new sales and margin expansion through a lower cost structure. To dig deeper into the company's financial standing, you should review the full analysis in Breaking Down Marchex, Inc. (MCHX) Financial Health: Key Insights for Investors.
Next Step for Analysts: Model the Q4 2025 guidance using a conservative revenue figure (sequentially lower than Q3's $11.5 million) and assess the cash burn rate against the current cash balance of $10.3 million as of the end of Q3 2025.
Growth Opportunities
You're looking at Marchex, Inc. (MCHX) right now and seeing a company in the middle of a major transformation, which means near-term risks but also significant upside. The direct takeaway is this: the company is transitioning from a legacy platform to a full AI-driven conversational intelligence solution, and the key to future growth hinges on the successful integration of its new products and a strategic acquisition.
The management team has been clear that 2025 is an inflection point, with a focus on platform migration and new product launches. This is a big move, and it's why Q3 2025 GAAP revenue of $11.5 million was down from the prior year, though the company did improve Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) to a gain of $1.1 million, net of reorganization costs, showing better operating leverage. That's a good sign they're managing costs even with the revenue dilution.
Future Revenue and Earnings Estimates
The financial picture for the full 2025 fiscal year is mixed, which is typical during a major platform overhaul. Analyst consensus for full-year 2025 revenue is approximately $50.40 million, with an expected earnings per share (EPS) of -$0.08. Here's the quick math: the company is investing heavily to build a better future, so they're not fully profitable yet.
The real story, however, is the 2026 outlook, which is where the new strategy is projected to pay off. Management anticipates that the combined entity, post-acquisition, could achieve an annualized revenue run rate of approximately $60 million, with a potential growth rate in the 15% to 20% range throughout 2026. Plus, they are targeting Adjusted EBITDA margins of 10% or more next year.
Key Growth Drivers and Strategic Moves
Marchex's growth is no longer about incremental improvements; it's about a wholesale shift to an AI-first, outcome-based model. The three main drivers are product innovation, strategic partnerships, and a crucial acquisition.
- Product Innovations: The launch of the new unified user interface and vertical AI capabilities is central. They released AI Benchmarking in October 2025 and expect to launch Marchex Engage GPT-their business-specific large language model-later in Q4 2025.
- Strategic Acquisition: The agreement in principle to acquire Archenia, Inc. is a game-changer. Archenia is a performance-based customer acquisition firm, and the combination will create a vertically focused, AI-driven platform that lets customers pay for verified, AI-validated outcomes like appointments or sales. This expands their addressable market significantly.
- Partnerships: Marchex is expanding its reach through key channel partners. In June 2025, they announced an expanded partnership with FordDirect to deliver their AI-Powered Engage solutions to approximately 3,000 Ford Dealers and Lincoln Retailers. They also have a strategic collaboration with Microsoft, making their solutions globally accessible via Azure.
Competitive Advantages in Conversational AI
Their competitive edge isn't just the technology itself, but the proprietary data feeding it. Marchex has an extensive repository of direct, first-party customer interaction data across their key vertical markets: Auto, Auto Services, Home Services, and Healthcare. This data is the fuel for their conversational intelligence platform, making their AI models more accurate and industry-specific than general-purpose solutions.
The completion of the underlying technology platform migration, often called the OneStack initiative, is defintely a big advantage, too. It has already contributed to improved gross profit margins, creating operating leverage that should help the bottom line as revenue scales. This focus on AI-driven solutions is positioning them to move beyond just providing insights to offering automated actions and verifiable outcomes, which is a much higher-value proposition for their enterprise customers. If you want to dive deeper into who is betting on this strategy, check out Exploring Marchex, Inc. (MCHX) Investor Profile: Who's Buying and Why?

Marchex, Inc. (MCHX) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.